BrainCare

BrainCare is an Oxford-based medical technology company developing a non-invasive wearable device designed for continuous intracranial pressure (ICP) monitoring. The company's core technology leverages photoplethysmography (PPG) signals to measure ICP non-invasively, eliminating the need for the surgical implantation traditionally required by gold-standard monitoring methods. This approach enables continuous, real-time neurological monitoring that can be deployed at the bedside without the risks and costs associated with invasive procedures. The device is purpose-built for clinical environments, targeting acute brain injury management and broader neurological monitoring applications.

BrainCare has secured $20 million in Series B funding, reflecting growing investor confidence in the company's technology and commercial trajectory. The capital positions BrainCare to advance its clinical validation efforts and accelerate the path toward regulatory approval and broader adoption within hospital and critical care settings. The company operates at the intersection of wearables, neuroscience, and critical care medicine, a space that demands rigorous clinical evidence, and its Oxford base provides strong proximity to leading academic medical institutions and research networks. These milestones signal a maturing organization moving from early-stage development toward clinical and commercial scale.

BrainCare addresses one of the most significant unmet needs in neurocritical care, where accurate ICP monitoring is essential but invasive techniques limit accessibility across many clinical contexts. By making continuous ICP monitoring non-invasive and wearable, the company has the potential to expand monitoring to a far broader patient population, including those in lower-resource settings or earlier stages of neurological deterioration. This could meaningfully improve outcomes for patients with traumatic brain injury, stroke, and other conditions where elevated intracranial pressure poses life-threatening risks. As the neurotech industry increasingly prioritizes patient-friendly, data-rich monitoring solutions, BrainCare represents a compelling example of how novel signal processing and sensor technology can transform standard of care in neurology.